Evidence map›Paper›PMID 34205023›Full record

ArticleDiagnostics (Basel, Switzerland)2021

Importance of Potential New Biomarkers in Patient with Serouse Ovarian Cancer.

Aneta Cymbaluk-Płoska, Karolina Chudecka, Anita Chudecka-Głaz, Katarzyna Piotrowska, Sebastian Kwiatkowski, Maciej Tarnowski

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Aneta Cymbaluk-PłoskaDepartment and Clinic of Gynaecological Surgery and Gynaecological Oncology of Adults and Adolescents, Pomeranian Medical University, ul. Powstańców Wlkp. 72, 70-111 Szczecin, Poland.
Karolina ChudeckaDepartment and Clinic of Gynaecological Surgery and Gynaecological Oncology of Adults and Adolescents, Pomeranian Medical University, ul. Powstańców Wlkp. 72, 70-111 Szczecin, Poland.
Anita Chudecka-GłazDepartment and Clinic of Gynaecological Surgery and Gynaecological Oncology of Adults and Adolescents, Pomeranian Medical University, ul. Powstańców Wlkp. 72, 70-111 Szczecin, Poland.
Katarzyna PiotrowskaDepartment of Physiology, Pomeranian Medical University, Powstańców Wlkp. 72, 70-111 Szczecin, Poland.ORCID 0000-0002-4472-0830
Sebastian KwiatkowskiDepartment of Obstetrics and Gynaecology, Pomeranian Medical University, ul. Powstańców Wlkp. 72, 70-111 Szczecin, Poland.ORCID 0000-0003-1504-3639
Maciej TarnowskiDepartment of Physiology, Pomeranian Medical University, Powstańców Wlkp. 72, 70-111 Szczecin, Poland.ORCID 0000-0002-3869-5077

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ovarian cancer remains the gynecological cancer with the highest mortality rate. In our study, we compare a number of proteins from different effector pathways to assess their usefulness in the diagnosis of ovarian cancer. The tissue expression of the tested proteins was assessed by two methods: qRT-PCR and an immunohistochemical analysis. A significantly higher level of mRNA expression was found in the ovarian cancer group for

Indexed as

ALD1A1CD71H2A.Xovarian cancerSMAD2SMAD3TEAD4TKTTKTL1YAP

Identifiers

PMID34205023
PMCPMC8227487

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.